Clinical Trial Update: Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial updating on the efficacy of a fluvastatin plus fenofibrate regimen versus a simvastatin plus ezetimibe regimen in patients with dyslipidemia and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Metabolic Syndrome

Drugs mentioned

• Lescol (fluvastatin)
• Tricor (fenofibrate)
• Zetia (ezetimibe)
• Zocor (simvastatin)

Snippet

Sponsor: Novartis | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED